Buchbinder Aby
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Buchbinder Aby. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| ENZN | VP, Clinical Development | Award / Grant | 3,748 | — | — | Jan 23, 2013 |
| ENZN | VP, Clinical Development | Award / Grant | 4,000 | — | — | Jan 17, 2012 |
| ENZN | VP, Clinical Development | Sale | 2,700 | $7.06 | $19,062 | Nov 8, 2011 |
| ENZN | VP, Clinical Development | Tax Withholding | 2,952 | $8.33 | $24,590 | Sep 15, 2011 |
| ENZN | VP, Clinical Development | Award / Grant | 8,000 | — | — | Aug 12, 2011 |